GH R&D Expenses

Guardant Health Inc · R&D Expenses

GH logo

GH R&D Expenses

Latest reported$375.79M
GH R&D Expenses ($10.86M → $375.79M)
High-resolution chart · PNG

GH r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Guardant Health Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
364,191,000
347,753,000
367,194,000
373,807,000
263,221,000
149,862,000
86,292,000
50,714,000
25,562,000
10,859,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.